Tofacitinib |
Butyl 4-cyano-3-imino-5-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate |
VE0010254 | View |
Tofacitinib |
Dihydro Tofacitinib Citrate Impurity |
VE008139 | View |
Tofacitinib |
Dihydro Tofacitinib Impurity |
VE008429 | View CAS 1640972-35-5 |
Tofacitinib |
Ethyl 4-cyano-3-imino-5-((3R, 4R)-4-methyl-3-(methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate |
VE0010253 | View CAS 2102039-99-4 |
Tofacitinib |
N, 4-dimethyl-1-nitrosopiperidin-3-amine |
VE0011039 | View |
Tofacitinib |
N, 7-dimethyl-N-((3S, 4S)-4-methyl-1-nitrosopiperidin-3-yl)-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-amine |
VE0011038 | View |
Tofacitinib |
N, 7-dimethyl-N-((3S, 4S)-4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2, 3-d]pyrimidin-4-amine |
VE0011037 | View |
Tofacitinib |
N-(1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)nitrous amide |
VE009892 | View |
Tofacitinib |
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide |
VE0011029 | View |
Tofacitinib |
N-Methyl-N-Nitroso-o-toulidine |
VE0011030 | View CAS 10596-01-7 |
Tofacitinib |
N-methyl-N-((3S, 4S)-4-methyl-1-nitrosopiperidin-3-yl)-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-amine |
VE0011034 | View |
Tofacitinib |
N-methyl-N-((3S, 4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-amine |
VE0011036 | View |
Tofacitinib |
N-methyl-N-((3S, 4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-7H-pyrrolo[2, 3-d]pyrimidin-4-amine |
VE0011035 | View |
Tofacitinib |
N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide |
VE0011040 | View |
Tofacitinib |
N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide |
VE0011041 | View |
Tofacitinib |
Tofacitinib Acid Impurity |
VE008140 | View CAS 2328165-36-0 |
Tofacitinib |
Tofacitinib Amide Impurity |
VE008141 | View CAS 1675248-19-7 |
Tofacitinib |
Tofacitinib Benzyl Impurity |
VE006715 | View CAS 477600-73-0 |
Tofacitinib |
Tofacitinib Citrate Diastereomer |
VE0010540 | View |
Tofacitinib |
Tofacitinib Impurity 45 |
VE0010096 | View CAS 2407039-29-4 |
Tofacitinib |
Tofacitinib Impurity 62 Citrate |
VE008307 | View CAS 1092578-47-6 |
Tofacitinib |
Tofacitinib Impurity 78 |
VE0010097 | View |
Tofacitinib |
Tofacitinib Impurity C Citrate |
VE006951 | View CAS 2174011-55-1 |
Tofacitinib |
Tofacitinib N-Descyanoacetyl Impurity |
VE006714 | View CAS 477600-74-1 |
Tofacitinib |
Tofacitinib N-oxide impurity |
VE008142 | View CAS 2028267-73-2 |
Tofacitinib |
1, 8-Diazabicyclo[5.4.0]undec-7-ene |
VE008082 | View CAS 6674-22-2 |
Tofacitinib |
3-((3R, 4R)-4-Methyl-3-(methyl(5-oxo-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
VE0010103 | View CAS 2101951-20-4 |
Tofacitinib |
3-((3R, 4R)-4-methyl-3-(methyl(6-oxo-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
VE0010102 | View CAS 1640971-51-2 |
Tofacitinib |
4-chloro-6, 7-dihydro-5H-pyrrolo[2, 3-d]pyrimidine |
VE009833 | View CAS 16372-08-0 |
Tofacitinib |
4-picoline, 1, 2, 3, 6-tetrahydro-1-nitroso |
VE0011032 | View |
Tofacitinib |
5, 7-dihydro-6H-pyrrolo [2, 3-d] pyrimidin-6-one impurity |
VE0010061 | View CAS 5817-96-9 |